Studies in Dermatology | Cypress, TX
Status
Conditions
Treatments
About
A randomized, open-label, investigational safety evaluation of the Microporous Annealed Particle (MAP) Wound Matrix (TT101) device as a volumetric biomaterial scaffold applied to clean wounds after skin cancer surgery with Mohs micrographic surgery (MMS) compared to control.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
_ Has a confirmed diagnosis of clinically significant peripheral neuropathy.
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Andrea Quach, BS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal